SHARON MASON: Open Payments
NPI 1104098557 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$799 in 40 payments from 7 companies in 2025. Trend: 2023 $523 · 2024 $844 · 2025 $799
Food & beverage: $799
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $312 |
| Vanda Pharmaceuticals Inc. | 9 | $227 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $115 |
| Axsome Therapeutics, Inc. | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Alkermes, Inc. | 2 | $37 |
| Supernus Pharmaceuticals, Inc. | 1 | $25 |
Products named: VRAYLAR, FANAPT, CAPLYTA, Auvelity, REXULTI, ARISTADA, Qelbree.
Industry payments across FL — which companies pay providers there.
